How NPS2 Helps Predict Progression Without Another Biopsy
Summary
- Learn how NPS2 tracks biomarker expression over time to help assess rising or stable prostate cancer risk without immediately resorting to biopsy
- Discover why urine-based tests may soon offer men on active surveillance a far more comfortable and informative way to monitor disease progression
- Uncover the next generation of prostate biomarker testing being designed specifically to predict grade progression—and how it could transform decision-making
- This video is part of the Prostate Cancer Summit 2.0
